TrialProstate cancer and prostatic diseases2026
Disease progression patterns and association of prostate-specific antigen level with risk of progression in nonmetastatic castration-resistant prostate cancer.
Alicia K Morgans et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.